FDA expands Merck's Ebola vaccine approval to children one year and older
The first FDA-approved Ebola vaccine, dubbed Ervebo, is now available to children as young as one year old, Merck announced today …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
